Literature DB >> 24158961

HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.

Paul R Gorry1, Nicholas Francella, Sharon R Lewin, Ronald G Collman.   

Abstract

Myeloid cells residing in the CNS and lymphoid tissues are targets for productive HIV-1 replication, and their infection contributes to the pathological manifestations of HIV-1 infection. The Envs can adopt altered configurations to overcome entry restrictions in macrophages via a more efficient and/or altered mechanism of engagement with cellular receptors. This review highlights evidence supporting an important role for macrophages in HIV-1 pathogenesis and persistence, which need to be considered for strategies aimed at achieving a functional or sterilizing cure. We also highlight that the molecular mechanisms underlying HIV-1 tropism for macrophages are complex, involving enhanced and/or altered interactions with CD4, CCR5, and/or CXCR4, and that the nature of these interactions may depend on the anatomical location of the virus.

Entities:  

Keywords:  CCR5; CD4; CXCR4; reservoir

Mesh:

Substances:

Year:  2013        PMID: 24158961      PMCID: PMC3868190          DOI: 10.1189/jlb.0713368

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  146 in total

1.  Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

Authors:  Paul J Peters; W Matthew Sullivan; Maria J Duenas-Decamp; Jayanta Bhattacharya; Chiambah Ankghuambom; Richard Brown; Katherine Luzuriaga; Jeanne Bell; Peter Simmonds; Jonathan Ball; Paul R Clapham
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 2.  HIV reservoirs and the possibility of a cure for HIV infection.

Authors:  S Palmer; L Josefsson; J M Coffin
Journal:  J Intern Med       Date:  2011-10-27       Impact factor: 8.989

Review 3.  The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.

Authors:  Paul R Gorry; Jasminka Sterjovski; Melissa Churchill; Kristie Witlox; Lachlan Gray; Anthony Cunningham; Steven Wesselingh
Journal:  Sex Health       Date:  2004       Impact factor: 2.706

4.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

5.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

Review 6.  HIV-1 envelope determinants for cell tropism and chemokine receptor use.

Authors:  T L Hoffman; R W Doms
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

7.  CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Authors:  Nicholas Francella; Sarah E Gwyn; Yanjie Yi; Bing Li; Peng Xiao; Sarah T C Elliott; Alexandra M Ortiz; James A Hoxie; Mirko Paiardini; Guido Silvestri; Cynthia A Derdeyn; Ronald G Collman
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 8.  A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.

Authors:  Janice E Clements; Lucio Gama; David R Graham; Joseph L Mankowski; M C Zink
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

9.  Uniform detection of HIV-1 in alveolar macrophages of pediatric but not adult AIDS patients.

Authors:  T E Pearce; M Nowakowski; E Eden; Z B Huang; P Steiner; M Shahabuddin; M J Potash; D J Volsky
Journal:  J Leukoc Biol       Date:  1993-06       Impact factor: 4.962

10.  A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo.

Authors:  Nadeene E Riddick; Emilia A Hermann; Lamorris M Loftin; Sarah T Elliott; Winston C Wey; Barbara Cervasi; Jessica Taaffe; Jessica C Engram; Bing Li; James G Else; Yingying Li; Beatrice H Hahn; Cynthia A Derdeyn; Donald L Sodora; Cristian Apetrei; Mirko Paiardini; Guido Silvestri; Ronald G Collman
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more
  17 in total

Review 1.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

Review 2.  Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.

Authors:  Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

3.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 4.  Paediatric HIV infection: the potential for cure.

Authors:  Philip J Goulder; Sharon R Lewin; Ellen M Leitman
Journal:  Nat Rev Immunol       Date:  2016-03-14       Impact factor: 53.106

5.  T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading.

Authors:  Lucie Bracq; Maorong Xie; Marie Lambelé; Lan-Trang Vu; Julie Matz; Alain Schmitt; Jérôme Delon; Paul Zhou; Clotilde Randriamampita; Jérôme Bouchet; Serge Benichou
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

6.  Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14lowCD16+ Monocyte Subsets in AIDS Patients.

Authors:  Junyan Han; Hongxin Zhao; Yaluan Ma; Haiwei Zhou; Yu Hao; Yanmei Li; Chuan Song; Ning Han; Xiangyi Liu; Hui Zeng; Mingzhao Qin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

7.  Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.

Authors:  Teresa H Evering; Edwin Kamau; Leslie St Bernard; Charles B Farmer; Xiang-Peng Kong; Martin Markowitz
Journal:  Retrovirology       Date:  2014-08-15       Impact factor: 4.602

8.  Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.

Authors:  Kelechi Chikere; Nicholas E Webb; Tom Chou; Katharina Borm; Jasminka Sterjovski; Paul R Gorry; Benhur Lee
Journal:  Retrovirology       Date:  2014-06-23       Impact factor: 4.602

9.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

10.  Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.

Authors:  Stephanie M Matt; Emily A Nickoloff-Bybel; Yi Rong; Kaitlyn Runner; Hannah Johnson; Margaret H O'Connor; Elias K Haddad; Peter J Gaskill
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.